alle kategorier
EN
Om os

Vi er den største BGM-produktionsvirksomhed i Asien, den årlige produktionskapacitet for glukosemåler er 8 millioner, og den årlige produktionskapacitet for glukoseteststrimmel er 6 milliarder.

BEDRIFTSHISTORIE

Aug.2002 -- Sinocare was founded

Feb. 2007 -- Passed ISO13485 and CE Certificate

Mar.2008 -- Approved by NDRC (National Development and Reform Commission) as “Biomedical Engineering Model Project”

2012 -- Listed on SZSE(Shenzhen Stock Exchange)

Oct.2013 -- To be the leading BGMS manufacturer in Asia

Sep.2014 -- Acquired Beijing Jianheng Diabetes Hospital, Entered The Field Of Medical Services

Jan. 2016 -- Acquired Nipro diagnostic Inc. (now renamed as Trividia Health Inc.), reaching the international leading Blood Glucose Monitor corporation

Oct. 2017 -- Oct. 2017 Gold AQ Blood Glucose Monitoring System Has received U.S. FDA 510(K) clearance.

May,2019 -- AGEscan, a non-invasive diabetes risk screening product, was launched at the 81st CMEF, opening a new entrance to the whole course management of diabetes

Oct.2020 -- iPOCT standardization laboratory is marketed officially in CMEF Shanghai

2002
2007
2008
2012
2013
2014
2016
2017
2019
2020

Sinocare Lu Valley Biosensor Manufacturing Facility, der ligger i Changsha National High-Tech Industrial Development Zone, blev lanceret i 2013. Med omkring 66,000 m2 bruttoareal bliver vores fabrik den største produktionsbase for blodglucoseovervågningssystem (BGMS) i Asien.

TILMELD DIG SINOCAR